Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeted radiosensitization by the Chk1 inhibitor SAR-020106.
Borst GR, McLaughlin M, Kyula JN, Neijenhuis S, Khan A, Good J, Zaidi S, Powell NG, Meier P, Collins I, Garrett MD, Verheij M, Harrington KJ. Borst GR, et al. Among authors: verheij m. Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1110-8. doi: 10.1016/j.ijrobp.2012.08.006. Epub 2012 Sep 14. Int J Radiat Oncol Biol Phys. 2013. PMID: 22981708
In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients.
Haas RL, de Jong D, Valdés Olmos RA, Hoefnagel CA, van den Heuvel I, Zerp SF, Bartelink H, Verheij M. Haas RL, et al. Among authors: verheij m. Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):782-7. doi: 10.1016/j.ijrobp.2003.11.017. Int J Radiat Oncol Biol Phys. 2004. PMID: 15183481
Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy.
Dikken JL, Coit DG, Baser RE, Gönen M, Goodman KA, Brennan MF, Jansen EP, Boot H, van de Velde CJ, Cats A, Verheij M. Dikken JL, et al. Among authors: verheij m. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):624-9. doi: 10.1016/j.ijrobp.2013.11.213. Epub 2014 Jan 7. Int J Radiat Oncol Biol Phys. 2014. PMID: 24411620
Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells.
Verhagen CV, de Haan R, Hageman F, Oostendorp TP, Carli AL, O'Connor MJ, Jonkers J, Verheij M, van den Brekel MW, Vens C. Verhagen CV, et al. Among authors: verheij m. Radiother Oncol. 2015 Sep;116(3):358-65. doi: 10.1016/j.radonc.2015.03.028. Epub 2015 May 13. Radiother Oncol. 2015. PMID: 25981132
The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development.
Kerkmeijer LG, Fuller CD, Verkooijen HM, Verheij M, Choudhury A, Harrington KJ, Schultz C, Sahgal A, Frank SJ, Goldwein J, Brown KJ, Minsky BD, van Vulpen M; MR-Linac Consortium Clinical Steering Committee. Kerkmeijer LG, et al. Among authors: verheij m. Front Oncol. 2016 Oct 13;6:215. doi: 10.3389/fonc.2016.00215. eCollection 2016. Front Oncol. 2016. PMID: 27790408 Free PMC article.
Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.
Borst GR, Kumareswaran R, Yücel H, Telli S, Do T, McKee T, Zafarana G, Jonkers J, Verheij M, O'Connor MJ, Rottenberg S, Bristow RG. Borst GR, et al. Among authors: verheij m. Oncotarget. 2020 Apr 28;11(17):1573-1574. doi: 10.18632/oncotarget.27476. eCollection 2020 Apr 28. Oncotarget. 2020. PMID: 32391125 Free PMC article.
318 results